Insight

Megan E. Tesch: Estrogen levels in young patients on OFS treatment for breast cancer

Photo taken from Megan E. Tesch/X

Aug 3, 2024, 06:00

Megan E. Tesch: Estrogen levels in young patients on OFS treatment for breast cancer

Megan E. Tesch, Medical oncologist at Dana-Farber Cancer Institute, shared on X:

“What are the clinical implications of incomplete ovarian function suppression? In this study we evaluate estrogen levels in young patients on OFS treatment for breast cancer with ultrasensitive assays and correlate with outcomes.

‘Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy‘

Authors: Megan E. Tesch, Yue Zheng, Shoshana M. Rosenberg, Philip D. Poorvu, Kathryn J. Ruddy, Rulla Tamimi, Lidia Schapira, Jeffrey Peppercorn, Virginia Borges, Steven E. Come, Craig Snow, Shalender Bhasin Ann H. Partridge.⁦”

Source: Megan E. Tesch/X

Breast Cancer cancer Craig Snow Jeffrey Peppercorn Kathryn J. Ruddy Lidia Schapira Megan E. Tesch OncoDaily Oncology Philip D. Poorvu Rulla Tamimi Shalender Bhasin Ann H. Partridge Shoshana M. Rosenberg Steven E. Come Virginia Borges Yue Zheng

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage